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ABSTRACT A computational approach, based on a continuum molecular electrostatics model, for the calculation of the pKa
values of secondary ionization of the phosphate group in phenyl phosphate derivatives is described. The method uses the ESP
atomic charges of the mono-anionic and di-anionic forms of the ionizable phosphate group, computed with the use of the
density functional method, and applies a new concept of the model group, being the reference state for the pKa calculations.
Both conformational ﬂexibility and tautomeric degrees of freedom are taken into account in the calculations. The method was
parameterized using experimentally available pKa values of four derivatives of phenyl phosphates, and phosphotyrosine.
Subsequently this parameterization was used to predict pKa of the phosphate group in a short peptide Gly-Gly-Tyr(P)-Ala, and
in a longer peptide consisting of 12 residues, the latter in water, and in a complex with a protein—phospholipase. The
agreement between the computed and the experimental pKa values is better than 60.3 pH units for the optimized solute
dielectric constant of 11–13. This approach is promising and its extension to other phospho-amino acids is in progress.
INTRODUCTION
Phosphate groups play a key role in the living world. They
are present in proteins, nucleic acids, and other biomolecular
systems, and no other residue appears to fulfill the multiple
roles in molecular biology (Westheimer, 1987). Reversible
phosphorylation of seryl, threonyl, tyrosyl, or histydyl res-
idues is one of the most abundant covalent modifications of
proteins which constitutes an ubiquitous mechanism for
controlling and regulating intracellular processes (Green-
gard, 1978; Walaas and Greengard, 1991; Beltman et al.,
1993; Kurosawa, 1994; Dekel, 1996; Patarca, 1996). A
phosphate group bound to an amino acid side chain has
either a single- or double-negative charge. The primary pKa
values of phosphoric acid and of phosphate mono-esters are
;2, which results in their at-least mono-anionic ionization
state at physiological pH. The secondary pKa of phosphoric
acid is 7.2 according to one source (Weast, 1966) and 6.7
according to the other (Peacock and Nickless, 1969). Also,
the secondary ionization constant of the phosphate group
in well-solvated phosphate mono-esters is close to the value
of 7. What is important, the total charge of the phosphate
groups in phospho-amino acids in a complex molecular
environment can be either 1 or 2. A knowledge of
whether the phosphate group is di-anionic or mono-anionic,
in particular, if the ionization state is affected by the presence
of ligands or other changes in the environment, is essential
for understanding the role played by this group in catalytic
events or in protein structure formation (Martinez-Liarte
et al., 1992; Johnson and Barford, 1994; Yang et al., 1994;
Mavri and Vogel, 1996; Mestas and Lumb, 1999; Antosie-
wicz et al., 2000). Ionization state of the bound phosphate
group in a protein or polypeptide can be determined by NMR
spectroscopy methods (Kalbitzer and Ro¨sch, 1981; Hoff-
mann et al., 1994) or a Fourier transform infrared spec-
troscopy (Sanchez-Ruiz and Martinez-Carrion, 1986). On
the other hand, during the past several years a significant
progress in the development of increasingly predictive
theoretical models for protonation equilibria in proteins is
observed (Bashford and Karplus, 1990; Yang et al., 1993;
Antosiewicz et al., 1994, 1996; Sham et al., 1997; Mehler
and Guarnieri, 1999). The previous theoretical approaches
dealt rather exclusively with standard amino acids encoun-
tered in proteins. Inasmuch as phosphorylation is common in
proteins, it would be desirable to also include phosphory-
lated side chains in the list of residues treated in standard
modeling methods. In this study an approach for prediction
of the secondary ionization constant of phosphotyrosine
(pTyr) in polypeptides and proteins is proposed.
METHODS
Theoretical background
A number of methods for theoretical prediction of protonation equilibria in
proteins use a concept of the model compound, which usually meant an
isolated amino acid, and an assumption that the difference in protonation
behavior of the model compound in an isolated state in solution, for which
the ionization constant is assumed to be known, and the protonation be-
havior in the protein environment, is purely electrostatic in origin
(Bashford and Karplus, 1990; Yang et al., 1993; Antosiewicz et al., 1994,
1996; Sham et al., 1997; Mehler and Guarnieri, 1999). Typically, the cor-
responding electrostatic energies are calculated for the model compound
with frozen conformations as they appear in the protein structural file. A
possibility of conformational movement of the protein was included in
a different manner by some authors (You and Bashford, 1995; Zhou and
Vijayakumar, 1997).
The present method makes one step further toward improvements of the
prediction of proton equilibria in proteins. Namely, instead of the model
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compound, a model group is introduced with its pKa(model) which can be
determined based on experimental pKa values of small molecules containing
the given group. The model group is characterized by the lowest possible
conformational flexibility, and it is reduced only to those atoms which
change their charge during deprotonation. A new understanding of
pKa(model) was presented in full detail elsewhere (Grycuk, 2002); therefore,
only the main features of this approach are presented below.
The standard free enthalpy of proton dissociation can be expressed as
follows:
DGo ¼ DGoðmodelÞ þ DDGoe ; (1)
where the DGoðmodelÞ term refers to the model system, and DDGoe
represents the electrostatic correction to the standard free enthalpy
DGoðmodelÞ. The pKa of the proton dissociation reaction is given as:
pKa ¼ pKaðmodelÞ þ DpKa; (2)
where the contribution DpKa ¼ DDGoe=2:303RT arises from the averaged
interaction between the model system and the rest of the molecule, and the
pKaðmodelÞ ¼ DGoðmodelÞ=2:303RT refers to the model system. For
a molecule with fixed conformation the following is valid:
DDGoe ¼ DGoe;u  DGoe;p; (3)
where DGoe;x (x ¼ p or u for the protonated and deprotonated state,
subsequently) represents the electrostatic work of moving the model group
from solvent to the molecule. A meaningful relation between pKa and
pKa(model) can be obtained if DDGoe is computed taking into account the
representative ensemble of conformations of the molecule. The free enthalpy
change, DDGoe , is defined as in Eq. 3, but now the contributions DGoe;x
represent the averaged electrostatic corrections for both protonation forms,
and they are calculated as follows:
DGoe;x ¼ RT ln+
k
eDGoe;xðkÞ=RT; (4)
therefore, finally:
pKa ¼ pKaðmodelÞ  12:303 ln
+ke
DGoe;uðkÞ=RT
+ke
DGoe;pðkÞ=RT : (5)
The summation extends over a representative ensemble of conformers
sampled from the trajectory of the Molecular Dynamics simulation with
suppressed electrostatics. The form of Eq. 5 indicates that contribution of
each conformer to the relation between pKa and pKa(model) is weighted by
the electrostatic work of moving the model group from solvent to the
molecule, DGoe;xðkÞfor the k-th conformer. This equation allows one to
estimate the pKa(model) based on the experimental pKa of a small molecule
containing the model group.
The calculated value of DDGoe depends on atomic partial charges and
radii of the solute molecule, as well as on the solute and solvent dielectric
constants and definition of the dielectric boundary between solute and sol-
vent. For each set of these parameters and definition of the boundary, the
pKa(model) reproducing the experimental pKa values of a given molecule
can be determined. In practice partial charges and radii of atoms are es-
tablished independently. This leaves a solute dielectric constant and the
pKa(model) as the only adjustable parameters in the model being applied for
prediction protonation equilibria based on the Poisson-Boltzmann model of
solute-solvent systems.
Having experimental pKa values of a number of small test molecules
containing the same model group, one can choose the solute dielectric
constant and corresponding pKa(model) according to Eq. 5 which give the
best reproduction of the experimental data for all the test molecules. Such
a procedure leads to solute dielectric constant substantially above values
expected on the basis of only electronic polarization contribution. It should be
stressed that the resultingpKa(model) and the solute dielectric constant are not
direct, physical observables and their values are adjustable parameters.
Atomic partial charges and force
ﬁeld parameters
Calculation of the electrostatic energy requires atomic charges and radii.
The atomic radii were taken from the CHARMM force field. Charge
parameterization for phosphotyrosine in two protonation states of the
phosphate group is available (Feng et al., 1996), but the corresponding partial
charges data for phenyl phosphate derivatives is not. Therefore, in this study
a set of atomic charges that fit the electrostatic potential in the gas phase, so-
called ESP charges, were computed using the Gaussian94 package (Frisch et
al., 1995). The density functional method, with the B3LYP exchange and
correlation functional and the 6–312þg(d,p) basis set, was chosen.
The ESP charges were computed for all phenyl phosphate derivatives and
for phosphotyrosine, for both ionization states of the phosphate group, i.e.,
the single- and double-ionized states. The calculations were carried out for
a set of molecular conformations of each molecule covering the available
conformational space of the system. The resulting charges were averaged
over all conformations. Some charges were additionally averaged due to the
local symmetry, e.g., CD1 and CD2 carbon atoms of the benzene ring. Such
approximation removes problems of predefined asymmetry.
One should note that the ESP charges were used exclusively in the
Poisson-Boltzmann calculations. The Molecular Dynamics simulations were
carried out with electrostatics switched off (see the next paragraph), and the
remaining parameters for these molecules were taken from the CHARMM
force field. Based on the computed ESP charges, the model group for phenyl
phosphate and its parameterization was proposed (see ESP charges in
Results).
Generation of an ensemble of structures
For all molecules considered in this study but the phospholipase-
dodecapeptide complex, an ensemble of structures was generated by
Langevin Dynamics method (Widmalm and Pastor, 1992) using the
CHARMM v2.26 software (Brunger and Karplus, 1988). The electrostatic
interactions were switched off, therefore the sampled structures were not
weighted by electrostatic energies. The simulation procedure consists of
a short minimization, a 6-ps equilibration, and the 200-ns dynamics. The
Langevin Dynamics was carried out with a 2-fs time step and the friction
coefficient FBETA ¼ 50 ps1. To avoid translational movement of the
whole system, a harmonic constraint was applied to the central atom. After
each 100 ps of dynamics, the current structure was saved, leading finally to
an ensemble of 2000 conformers. Adding new conformers did not change
the value of the pKa(model). In the case of phospholipase-dodecapeptide
complex, a set of 18 NMR-based structures was used (Pascal et al., 1994),
available in the Protein Data Bank (PDB; Bernstein et al., 1977) under
access code 2PLE.
Parameterization of the pKa(model) versus
solute dielectric constant
For each structure sampled from the Langevin trajectory, the electrostatic
contribution to the free enthalpy was calculated using the UHBD software
(Davis et al., 1991). The method is based on a continuum dielectric model,
and the linear form of the Poisson-Boltzmann equation. The equation was
solved using a finite difference method (FDPB). We used standard
parameters for the solvent dielectric constant (78.0 for water), solvent probe
radius of 1.4 A˚, ion strength of 150.0 mM, and ion exclusion radius of 2.0 A˚.
There is no standard value of the solute dielectric constant for proteins; its
value changes depending on the local environment, the approximations
made, and the atom charges applied (Gilson and Honig, 1986; Nakamura
et al., 1988; Sham et al., 1997; Schutz and Warshel, 2001). To find the most
appropriate solute dielectric constant for the phosphate group in phenyl
phosphates and related compounds, the four phenyl phosphate derivatives
and phosphotyrosine were parameterized as follows. The DGQe;xcontributions
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(see Eq. 4) for all these molecules, for the protonated and deprotonated states
of their titratable sites, were computed for the solute dielectric constant
ranging from 5 to 20. These energies allow parameterization of the
pKa(model) as a function of the solute dielectric constant, using Eq. 5.
Experimental data for all the molecules are presented in Table 1. The
experimental data for the first five molecules were used for parameterization,
and the data for the last three molecules were used for comparison between
the experiment and our theoretical prediction.
Two sets of parameters were determined. First, four phenyl phosphate
derivatives were used as reference data. For each molecule of the four,
pKa(model) was calculated. Subsequently the four dependencies were
averaged. The purpose was to obtain pKa(model), which is independent of
small changes in parameterization of the model group. By assumption, the
model group in each of both protonation states has the same characteristics
in any environment. Second, the pKa values of phosphotyrosine were used
for parameterization. There are two published values, 5.80 (Vogel, 1989)
and 5.55 (Robitaille et al., 1991), for the experimental pKa values for
phosphotyrosine. Parameterizations were performed for both of them,
independently.
Application to the tetra- and dodecapeptide
and to a complex of the dodecapeptide
with phospholipase C-g1
The methodology described above was applied to predict protonation
equilibria for phosphotyrosine in two polypeptide chains, the tetrapeptide
(Gly-Gly-pTyr-Ala) and the dodecapeptide (Asp-Asn-Asp-pTyr-Ile-Ile-Pro-
Leu-Pro-Asp-Pro-Lys), and for a complex of the latter with the C-terminal
SH2 domain of phospholipase C-g1. The pKa value for phosphotyrosine in
the tetrapeptide was determined as 5.90 (Hoffmann et al., 1994). The pKa of
6.1 was determined for phosphotyrosine in the free dodecapeptide, whereas
in the complex with the SH2 domain the value of 4.0 was measured (Singer
and Forman-Kay, 1997).
RESULTS
ESP charges
All model compounds chosen for parameterization contain
the same model group. It is composed of the whole
phosphate group and the three carbons from the tyrosine
ring, i.e., the CZ, CE1, and CE2 atoms. Table 2 presents the
computed, ESP, and B3LYP//6–312þg(d,p) partial charges
of the atoms forming the model group in the phenyl
phosphate derivatives and related compounds. These charges
were common for all the derivatives used for parameteriza-
tion, and several charges of atoms, like phosphate oxygens,
were averaged, assuming the local symmetry. The computed
charges, using the 6–312þg(d,p) basis set, are quite large;
e.g., at the phosphorus they are þ1.50 and þ1.85 for the
protonated and deprotonated state, respectively. Note that the
more negative phosphate group has the more positive
phosphorus atom.
Dependence of pKa(model) on the solute
dielectric constant e
Table 3presents the computedpKa(model) values as functions
of the solute dielectric constant, together with the average
value over the four phenyl phosphate derivatives used in the
parameterization. The differences between the computed de-
pendencies for the phenyl phosphate derivatives can be con-
sidered as a measure of errors of our method resulting from
the uncertainty of experimental data and approximations of
the model. One should note that such approximations are in-
herent to all molecular modeling methods.
Table 4 presents dependence of the computed pKa(model)
as a function of the solute dielectric constant, based on two
TABLE 1 Experimental pKa values for the
examined molecules
Molecular system pKa Ref.*
Phosphoric acid monophenyl ester 5.83 [1–5]
Phosphoric acid mono-(4-bromo-phenyl) 5.44 [1]
p-Nitrophenyl phosphate 5.20 [4]
Phosphoric acid mono-(4-chloro-phenyl ester) 5.84 [6,7]
Phosphotyrosine 5.55 [8]
Phosphotyrosine 5.80 [9]
Short peptide, Gly-Gly-Tyr(P)-Ala 5.90 [10]
Dodecapeptide 6.10 [11]
Dodecapeptide-phospholipase complex 4.0 [11]
*References cited in the Table: [1], King and Delory, 1939; [2], Chanley
and Feageson, 1955; [3], Bourne and Williams, 1984; [4], Kimura et al.,
1997; [5], Gupta et al., 1987; [6], Maguire and Shaw, 1953; [7], Phillips,
1958; [8], Robitaille et al., 1991; [9], Vogel, 1989; [10], Hoffmann et al.,
1994; [11], Singer and Forman-Kay, 1997.
TABLE 2 Atomic charges in the model group
Atom name Mono-anionic form Di-anionic form
H 0.42 
O3 0.73 1.06
P 1.50 1.85
O1 0.92 1.06
O2 0.92 1.06
OZ 0.50 0.72
CZ 0.35 0.45
CE1 0.10 0.20
CE2 0.10 0.20
TABLE 3 The pKa(model) as a function of the solute
dielectric constant for the phenyl phosphate derivatives used
in this work, and the average value of the pKa(model)
Dielectric
Phenyl phosphate derivatives
Average
constant Br Cl H NO2 pKa(model)
5 5.41 5.78 5.53 5.68 5.60
6 5.34 5.71 5.50 5.53 5.52
7 5.30 5.67 5.48 5.43 5.47
8 5.26 5.64 5.47 5.35 5.43
9 5.24 5.62 5.46 5.29 5.40
10 5.22 5.60 5.45 5.24 5.38
12 5.19 5.57 5.44 5.17 5.34
14 5.17 5.55 5.43 5.12 5.32
15 5.16 5.54 5.43 5.09 5.31
17 5.14 5.52 5.42 5.04 5.28
20 5.11 5.50 5.41 4.98 5.25
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available experimental pKa values for phosphotyrosine, in
the e range from 5 to 20. It can be noted that both pa-
rameterizations are different from the data obtained for the
four derivatives of phenyl phosphate. However, the value of
the pKa(model) for the phosphotyrosine data obtained for the
measured pKa value of 5.80 and the average dependence
derived from the four phenyl phosphate derivatives are close,
starting from e ¼ 14.
It can also be noted that pKa(model) is the decreasing
function of e for the phenyl phosphate derivatives and it
is the increasing function for phosphotyrosine. Different
dependence of pKa(model) in the phenyl phosphate
derivatives and in phosphotyrosine can be explained by
interactions of the model group with the charges in its
neighborhood, i.e., CD1, CD2, HD1, and HD2. For the
phenyl phosphate derivatives these atoms have the net
positive charge close to 0. For phosphotyrosine the net
charge is ;0.1. The negative charge at the nearest
neighborhood of the protonation site makes the pKa(model)
lower than a positive charge would, and that effect should
gradually disappear with the increase of e.
Predicted pKa values for
tetra- and dodecapeptide
The tetrapeptide and the uncomplexed dodecapeptide were
used to check applicability of ourmethod for prediction ofpKa
values. Regarding conformational flexibility, thosemolecules
were treated in the same way as described above. For each
of them, 2000 structures were sampled from the Langevin
Dynamics trajectories with the electrostatic interactions
switched off. The pKa(model) value, based on the four phenyl
phosphate derivatives or phosphotyrosine, with the corre-
sponding solute dielectric constant,were used to calculatepKa
of the phosphate group in these peptides (see Eq. 4).
Calculations for the dodecapeptide complex with phos-
pholipase were carried out for several sets of structures out of
18 deposited in the PDB file (Pascal et al., 1994), beginning
from the first six structures up to all 18 structures. This pro-
cedure was applied because proper averaging would re-
quire knowledge of the probabilities of structures and this
information was not available. Nevertheless, starting from
the first six structures up to all 18 from the PDB file, the best
solute dielectric constant is always in the range of 11–14. All
parameterizations of the pKa(model), i.e., two for phospho-
tyrosine and the third for phenyl phosphate derivatives, give
similar accuracy in prediction of the pKa values.
The pKa(model) parameterization derived from the pKa
value of 5.55 for phosphotyrosine gives the best agreement
with the experimental pKa for the dodecapeptide-phospho-
lipase complex, regardless of the number of structures used
in the calculations. However, the same parameterization
gives worse agreement with the experiment for tetrapeptide
and dodecapeptide in water. The remaining two parameter-
izations give values of pKa close to each other. These
parameterizations give a similar level of accuracy for
dodecapeptide complexed with protein as the first param-
eterization, and moreover, give better agreement with the
experimental pKa values of the peptides in aqueous
environment.
Tables 5–7 show the best results together with the
corresponding solute dielectric constant, along with the
results for the most optimal solute dielectric constant, both
for each set of parameters. The results of the calculations
based on the first eight structures from the PDB file for the
peptide-protein complex are presented in Tables, as well as
in Fig. 1.
Note that the values of the optimal solvent dielectric
constant for each of the molecules differ, and spread in range
from 7 to 20. The pKa values obtained for the solute di-
electric constant from this range differ from that obtained for
the solute dielectric constant of 12 not more than 0.25 pH
unit. That difference could be considered as an error arising
from the applied approximations and it is close to the
experimental error. Inclusion of the conformational flexibil-
ity does not lower the solute dielectric constant to the value
of ;2, which could be interpreted as arising from the effect
of electronic polarization. High value of the solute dielectric
constant correlates also with previous results (Gilson and
TABLE 4 The pKa(model) as a function of the solute
dielectric constant for phosphotyrosine. Two available
experimental values are taken into account
Dielectric
constant
Phosphotyrosine
pKa(exp) ¼ 5.80*
pKa(model)
pKa(exp) ¼ 5.55y
4 5.03 4.78
5 5.08 4.83
6 5.13 4.88
7 5.16 4.91
8 5.18 4.93
9 5.19 4.94
10 5.19 4.94
12 5.21 4.96
14 5.22 4.97
17 5.24 4.99
20 5.27 5.02
*Robitaille et al., 1991; yVogel, 1989
TABLE 5 The pKa determined experimentally and computed,
based on the parameterization for the model compounds
Molecule
Experimental
pKa
Computed
pKa for e ¼ 12
Optimal
pKa(e)
Tetrapeptide
Dodecapeptide:
5.9 5.75 5.90 (e ¼ 7)
Uncomplexed 6.1 6.35 6.12 (e ¼ 20)
Complexed 4.0 3.93 3.93 (e ¼ 12)
The results for the optimal e ¼ 12 are presented in column 3. The best
results for particular calculations are presented in column 4. The solute
dielectric constants used in the calculations are given in the parentheses.
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Honig, 1986; Nakamura et al., 1988; Sham et al., 1997;
Schutz and Warshel, 2001). One of the present authors
(T.G.) also obtained the high solute dielectric constant (12.0)
using the CHARMM charges exclusively (Grycuk, 2002).
Therefore, it should be noted that arriving at the optimal
solute dielectric constant of ;12 is not a result of using
the ESP charges for the titrated phospho residues and the
CHARMM charges for other standard amino acids; it is the
property of the model. This is quite an important observation
because the ESP charges can be easily computed, using ab
initio methods, whereas further optimization of the charges
(as well as other force field parameters) is not a straightfor-
ward procedure.
Fig. 1 presents results for the dodecapeptide complexed
with phospholipase for each set of parameters, as functions
of the solute dielectric constant.
DISCUSSION
Answering the question whether a phosphate group is single
or doubly ionized in a real molecular environment, for
example being bound to a protein molecule, is of key
importance for studying and understanding the role of
phosphorylation processes in activation of biomolecules. In
particular, in our previous studies (B1achut-Okrasin´ska et al.,
1999; Antosiewicz et al., 2000) we have shown that the
ionization state of phosphate groups may depend, or be
coupled to, conformational changes of phosphorylated
proteins. Information on ionization states of the phosphate
groups is also required when analyzing mechanisms of the
phosphorylation processes by kinases and phosphatases at
the atomic level. The method proposed in this study allows
us to predict pKa values of the secondary ionization of
phosphate groups bound to tyrosines in peptides, with
FIGURE 1 Dependence of the predicted pKa
value for phosphotyrosine in the dodecapeptide
complexedwith phospholipase, on the solute di-
electric constant for the three parameteriza-
tions described in the text.
TABLE 6 The pKa determined experimentally and computed,
based on the parameterization for phosphotyrosine with the
experimental pKa 5 5.55
Molecule
Experimental
pKa
Computed
pKa for e ¼ 12
Optimal
pKa(e)
Tetrapeptide 5.9 5.36 5.37 (e ¼ 20)
Dodecapeptide:
uncomplexed 6.1 5.66 5.80 (e ¼ 20)
complexed 4.0 3.71 4.16 (e ¼ 13)
The results for the optimal e ¼ 12 are presented in column 3. The best
results for particular calculations are presented in column 4. The solute
dielectric constants used in the calculations are given in the parentheses.
TABLE 7 The pKa determined experimentally and computed,
based on the parameterization for phosphotyrosine with the
experimental pKa 5 5.80
Molecule
Experimental
pKa
Computed
pKa for e ¼ 12
Optimal
pKa(e)
Tetrapeptide 5.9 5.61 5.63 (e ¼ 20)
Dodecapeptide:
uncomplexed 6.1 6.14 6.11 (e ¼ 20)
complexed 4.0 3.74 4.10 (e ¼ 10)
The results for the optimal e ¼ 12 are presented in column 3. The best
results for particular calculations are presented in column 4. The solute
dielectric constants used in the calculations are given in the parentheses.
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accuracy of ;60.3 pH units, when the solute dielectric
constant of 11–13 is assumed. This promising approach is
now being extended to other phosphorylated peptides; in
particular, those which contain phosphorylated serine and/or
threonine.
It should be noted that although we applied the ESP
charges for the phosphorylated molecules, rather than the
CHARMM charges, not available for these compounds, it
seems to have a little influence on the results of the present
work, i.e., on the achieved agreement with the experimental
pKa values and the estimated best solute dielectric constant.
A very similar solute dielectric constant was obtained based
exclusively on molecules fully parameterized with the
CHARMM force field (Grycuk, 2002). This suggests that
the procedure described here is of quite general applicability.
Summarizing, the main steps of the applied procedure are
the following:
1. Search for experimental pKa values for a model com-
pound (e.g., amino acid), possibly closest to your
titratable subunit.
2. Calculate the ESP charges for all possible protonation
states of any new titratable subunit present in your
biopolymer. If parameterization for all subunits is
available, skip this point.
3. Define the model group within the titratable subunit
which is described by the lowest possible conformational
flexibility, and reduced exclusively to those atoms which
change their charge during deprotonation.
4. Perform the Langevin Dynamics simulation for the
model compound with the suppressed electrostatic
interactions, to generate the representative ensemble of
structures (here, 2000 structures).
5. Perform the Poisson-Boltzmann calculations to deter-
mine the electrostatic contributions DGoe;xðkÞ for the
ensemble of structures in both protonation states and for
a selected dielectric constant of the solute molecule. The
solvent dielectric constant assumes its experimental value
(78 for water).
6. Apply Eq. 5 to find the pKa(model) for the selected solute
dielectric constant.
7. If you want to optimize the solute dielectric constant
(here ;12), repeat points 5 and 6 for different
dielectric constants.
This point completes the parameterization procedure. Now,
the computed pKa(model) may be used along with
pKa(model) of other groups when performing multiple
titration procedure for the biopolymer.
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